Employers can normalize behavioral health discussions, attorney says

At Rupp Baase Pfalzgraf Cunningham LLC, Matthew Miller guides the firm ’s the firm’s labor and employment practice. One of his specialties is offering assistance to a business as it navigates complex state and federal regulations that affect what companies must provide for employees and how they should treat them. Miller took a time out to answer some questions m any people in the business world continually have as mental health and addiction awareness grows. What can you do if you think an…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by the hypothalamus. The main biological actions of orexins, focused on the central nervous system, are to control the sleep/wake process, appetite and feeding, energy homeostasis, drug addiction, and cognitive processes. These effects are mediated by two G protein-coupled receptor (GPCR) subtypes named OX1R and OX2R. In accordance with the synergic and dynamic relationship between the nervous and immune systems, orexins also have neuroprotective and immuno-regulatory (i.e., anti-inflammatory) properties. The present review gathers recen...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Publication date: Available online 20 October 2019Source: International Journal of PsychophysiologyAuthor(s): Eliana Vassena, Filip Van Opstal, Ingeborg Goethals, Tom VergutsAbstractThe ability to exert control has been widely investigated as a hallmark of adaptive behaviour. Dopamine is recognized as the key neuromodulator mediating various control-related processes. The neural mechanisms underlying the subjective perception of being in control, or Locus of Control (LOC) are however less clear. LOC indicates the subjective tendency to attribute environmental outcomes to one's actions (internal LOC) or instead to external ...
Source: International Journal of Psychophysiology - Category: Psychiatry & Psychology Source Type: research
Authors: Arezoomandan R, Aliaghaei A, Khodagholi F, Haghparast A Abstract Glial glutamate transporters (GLT-1) is responsible for glutamate homeostasis. GLT-1 expression and glutamate uptake can be affected by addictive drugs and can be used as a target in addiction pharmacotherapy. It has been shown that minocycline, an antibiotic with anti-inflammatory, and neuroprotective properties, can upregulate the expression of GLT-1. In the present study, in morphine-dependent rats, the effect of minocycline on expression of GLT-1 in nucleus accumbens was investigated by immunohistochemistry. The expression of GLT-1 signif...
Source: Asian Journal of Psychiatry - Category: Psychiatry Tags: Asian J Psychiatr Source Type: research
Four large drug companies reached a last-minute $260 million legal settlement on Monday over their role in the U.S. opioid addiction epidemic, striking a deal with two Ohio counties to avert the first federal trial over the crisis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Talks to reach a settlement of thousands of lawsuits stemming from the U.S. opioid addiction crisis could resume as soon as Tuesday, an attorney for local governments said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Teva and distributors’ deal came as first federal trial on US addiction crisis was due to open
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Condition:   Heroin Dependence Intervention:   Behavioral: methadone induced memory retrieval-extinction procedure Sponsor:   National Institute on Drug Dependence, China Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Addiction Intervention:   Device: ASC Sponsor:   Assistance Publique - Hôpitaux de Paris Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Smartphone Users, Smartphone Addiction, Anxiety, and Skin Conductance Intervention:   Device: social media stimuli (Line app) Sponsor:   Kaohsiung Medical University Chung-Ho Memorial Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cancer Interventions:   Other: Psychosocial Navigator;   Other: Communication of Summary Profile Sponsors:   The Hospital for Sick Children;   Centre for Addiction and Mental Health Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Addiction | Biotechnology | Employment | Health Management | Men